Systemic Immune-Inflammation Index a Strong Predictor of Outcomes in Patients with DLBCL
A study found that the systemic immune-inflammation index (SII) is [...]
lymphoma
Systemic Immune-Inflammation Index a Strong Predictor of Outcomes in Patients with DLBCL
| Categories: lymphoma
A study found that the systemic immune-inflammation index (SII) is a robust prognostic tool for diffuse large B cell lymphoma (DLBCL). To conduct this study, […]
Study Shows 18F-FDG PET Textural Features as Predictors of Treatment Response in Diffuse Large B-cell Lymphoma
A study found that increased 18F-FDG PET/CT heterogeneity may predict [...]
Total Lesion Glycolysis and National Comprehensive Cancer Network International Prognostic Index as Predictors of Survival in DLBCL
Total lesion glycolysis (TLG) and National Comprehensive Cancer Network International [...]
Assessing the Predictive Value of EZH2 Expression Level on the Prognosis of Patients with Primary Gastrointestinal DLBCL
A high expression of methyltransferase EZH2 shortens survival in patients [...]
Infused Autograft-Absolute Lymphocyte Count Predicts Better Survival in DLBCL
Diffuse large B-cell lymphoma (DLBCL) patients infused with an autograft [...]
Assessing the Expression of miRNAs as Biomarkers for Predicting Outcomes in Patients with DLBCL
A study identified several potential miRNAs as biomarkers for diffuse [...]
Assessing Diagnosis-to-Treatment Intervals In DLBCL
A study published in the Journal of Clinical Oncology characterized [...]
Examining the Relationship Between Polymorphism of miR-155 and Its Target Gene MyD88 in DLBCL
A study found that the expression of miR-155 and the [...]
A Subgroup of Patients with DLBCL Might Not Benefit from Current Treatment Strategies
Some patients with primary refractory diffuse large B-cell lymphoma (DLBCL) [...]
Maintenance Therapy Unideal for Patients with Newly Diagnosed DLBCL
Researchers of a study do not recommend maintenance therapy in [...]
Correlation Between Diagnosis-to-Treatment Interval and Circulating Tumor DNA Levels in DLBCL
Short diagnosis-to-treatment (DTI) and circulating tumor DNA (ctDNA) levels in [...]
iFLT-PET/CT versus iFDG-PET/CT in Predicting DLBCL Outcomes
Interim 3′-deoxy-3′-[18F]fluorothymidine (iFLT) PET/CT was superior to interim 18F-fluorodeoxyglucose (iFDG) PET/CT [...]
Treatment Protocols Vary by Disease Stage in Sinonasal DLBCL
A study assessed different treatment modalities for patients with sinonasal [...]
Surgery a Beneficial Option for Primary Intestinal DLBCL
A study found that surgery may be a beneficial treatment [...]
Factors Influencing Risk of Second Malignant Neoplasms in DLBCL
The risk of second malignant neoplasms (SMNs) in patients with [...]
